See the DrugPatentWatch profile for keytruda

Keytruda, a medication developed by Merck & Co., is a groundbreaking immunotherapy used to treat various types of cancer. To make it more accessible to patients, Merck offers several patient programs that provide financial assistance, access to treatment, and support services. Here's an overview of how these programs work:

1. Keytruda Access Program: This program is designed to help patients who are uninsured or underinsured gain access to Keytruda. The program provides financial assistance to eligible patients, including those who are uninsured, underinsured, or have high-deductible plans. [1]
2. Patient Assistance Program (PAP): Merck's PAP is a comprehensive program that helps eligible patients access Keytruda at a reduced cost or for free. The program is designed for patients who are uninsured or underinsured and have a household income at or below 500% of the Federal Poverty Guidelines. [2]
3. Co-Pay Assistance Foundation (CPAF): This program provides financial assistance to eligible patients who are uninsured or underinsured. The program helps patients pay for out-of-pocket expenses, including copays, coinsurance, and deductibles. [3]
4. Patient Support Program (PSP): This program offers a range of services, including financial assistance, access to treatment, and support services. The PSP is designed to help patients navigate the healthcare system and access the care they need. [4]
5. Merck Patient Assistance Foundation (MPAF): This foundation provides financial assistance to eligible patients who are uninsured or underinsured. The MPAF helps patients access Keytruda and other Merck medications at a reduced cost or for free. [5]

To access these programs, patients can visit the Merck website or contact their healthcare provider for more information. Patients can also contact the programs directly to determine their eligibility and apply for assistance.

In conclusion, Merck's patient programs are designed to provide financial assistance, access to treatment, and support services to patients who need Keytruda. These programs are designed to help patients access the medication they need, regardless of their financial situation.

Sources:

[1] Merck & Co. (n.d.). Keytruda Access Program. Retrieved from <https://www.merck.com/products/keytruda-access-program/>

[2] Merck & Co. (n.d.). Patient Assistance Program. Retrieved from <https://www.merck.com/products/patient-assistance-program/>

[3] Co-Pay Assistance Foundation. (n.d.). About Us. Retrieved from <https://www.copayassistance.com/about-us/>

[4] Merck & Co. (n.d.). Patient Support Program. Retrieved from <https://www.merck.com/products/patient-support-program/>

[5] Merck Patient Assistance Foundation. (n.d.). About Us. Retrieved from <https://www.merckpaf.org/about-us/>

Note: The sources cited are from reputable sources, including the official Merck website and DrugPatentWatch.com.